Labiotech.eu

News and Trends 21 Jun 2022

Therorna funding to accelerate circRNA-based platform

Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based new vaccines and therapies, including for COVID-19, has completed a $42 million series A financing round. The funding was co-led by MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital. […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Elypta raises $21M to develop early detection test for all cancers

Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, has raised $21 million in a series A financing round led by Bonnier Ventures. “The series A is a pivotal moment for Elypta as it fully funds the development of our two leading indications,” said Karl […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

conveyor belt of medical vials for scale up production

News and Trends 21 Jun 2022

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T trial named “IMAGINE.” The Indian company focuses on creating access to Chimeric Antigen Receptor T cell therapy (CAR-T) and other cellular immunotherapies for the management and treatment of cancers. The phase II trial is the first industry sponsored CAR-T trial […]

June 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Biotalys and Novozymes partner on biofungicide

Belgian agtech company Biotalys and Danish biotech company Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol product. Novozymes will explore additional routes for the upscaling and production of the bioactive protein of Evoca, with the option of a possible commercial collaboration for a future generation of the product. […]

June 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Elektrofi raises $40M to develop drug formulation and delivery pipeline

Boston, U.S.-based biotech Elektrofi has completed a $40 million series B funding round. The company, which focuses on drug formulation and delivery, will use a portion of the proceeds to establish a centralized manufacturing line to support multiple upcoming clinical trials. The company also aims to double staff numbers over the next 12-18 months to […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

New agreement could lead to first African-owned COVID-19 vaccine

A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together. The agreement intends to pave the way for the development of the first African-owned COVID-19 vaccine. The collaboration will focus on the development of a novel mRNA […]

June 21, 2022 - 4 minutesmins - By Jim Cornall

stem cells, stem cell technology, lab-grown meat

News and Trends 21 Jun 2022

Aussie uni develops new 3D printing solution for stem cell manufacturing

Researchers at the University of Technology Sydney (UTS), Australia, have developed a 3D printed system for harvesting stem cells from bioreactors. The scientists said this could lead to high quality, wide-scale production of stem cells in Australia at a lower cost. Stem cells offer great promise in the treatment of many diseases and injuries, from […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

Inside Labiotech 21 Jun 2022

How you can get involved in helping the industry–academia community solve global challenges

IN-PART’s ‘Global Challenge’ campaigns were born out of the response to COVID-19 in March 2020. As the impacts of the pandemic began to take hold, IN-PART recognized its position at the interface of industry and academia and its responsibility to leverage its networks to generate solutions to the unfolding crisis. Through online matchmaking platforms, IN-PART […]

June 21, 2022 - 3 minutesmins - By External Contributor

News and Trends 20 Jun 2022

Investment in Hyperthermics’ process to turn biowaste into energy and proteins

Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS. Through the investment, Farvatn and Måsøval now hold approximately 11% of the shares in Hyperthermics. Hyperthermics’ technology is based on hyperthermophilic bacteria, which degrade biomass, resulting in biogas and protein production. The high temperatures involved – 80ºC – speed up […]

June 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Jun 2022

Boost for dementia gene-based therapies

The Cell and Gene Therapy Catapult (CGT Catapult) and the UK Dementia Research Institute (UK DRI) have announced a collaboration to accelerate the clinical development of adeno-associated virus (AAV) based gene therapies for dementia. Since 2015, dementia has been one of the leading causes of mortality in the UK. While new and improved treatments for […]

June 20, 2022 - 3 minutesmins - By Jim Cornall

Paris France biotech healthcare life sciences

In Depth 20 Jun 2022

France’s grand plan to lead Europe’s biotech innovation landscape

For decades, the French biotech scene has been catching up to key strongholds such as the U.S. and U.K. In the aftermath of the COVID-19 pandemic, the French government last year bet €7.5 billion on an ambitious project to turn France into Europe’s health innovation magnet by 2030. France is one of Europe’s most established […]

June 20, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 17 Jun 2022

ImCheck raises €96M in funding round

French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody drugs with the ability to activate the powerful immune cells called gamma delta T (gdT). The Marseille-based company hopes it will reach a wider range of cancer immunotherapy with the antibody drugs that include a lead candidate in the development […]

June 17, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Therorna funding to accelerate circRNA-based platform

Elypta raises $21M to develop early detection test for all cancers

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Biotalys and Novozymes partner on biofungicide

Elektrofi raises $40M to develop drug formulation and delivery pipeline

New agreement could lead to first African-owned COVID-19 vaccine

Aussie uni develops new 3D printing solution for stem cell manufacturing

How you can get involved in helping the industry–academia community solve global challenges

Investment in Hyperthermics’ process to turn biowaste into energy and proteins

Boost for dementia gene-based therapies

France’s grand plan to lead Europe’s biotech innovation landscape

ImCheck raises €96M in funding round

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!